Moderna
MRNA
#1455
Rank
NZ$21.27 B
Marketcap
$53.91
Share price
-2.23%
Change (1 day)
-65.72%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Total assets

Total assets on the balance sheet as of September 2024 : NZ$28.14 Billion

According to Moderna 's latest financial reports the company's total assets are NZ$28.14 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Moderna - Total assets on balance sheet (from 2017 to 2024)

Total assets by year

Year Total assets Change
2023-12-31NZ$29.13 B-28.46%
2022-12-31NZ$40.72 B12.77%
2021-12-31NZ$36.11 B255.18%
2020-12-31NZ$10.16 B330.87%
2019-12-31NZ$2.36 B-19.32%
2018-12-31NZ$2.92 B91.56%
2017-12-31NZ$1.52 B-25.36%
2016-12-31NZ$2.04 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
NZ$0.16 B-99.41%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$209.32 B 643.73%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$13.22 M-99.95%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$7.55 B-73.17%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$182.10 B 547.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$1.80 B-93.59%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$320.76 B 1,039.68%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA